Detection of Anti-Neutrophil Cytoplasmic Antibodies in MRL/Mp-lpr/lpr Mice and Analysis of their Target Antigens

References

• Savige J, Gillis D, Benson E, Davies D, Esnault V, Falk R J, et al. International Consensus Statement on Testing and Reporting of Antineutrophil Cytoplasmic Antibodies (ANCA). Am. J. Clin. Pathol 1999; 111: 507–13
   PubMed Web of Science ®Google Scholar
• Falk R J, Jennette J C. Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N. Engl. J. Med. 1988; 318: 1651–7
   PubMed Web of Science ®Google Scholar
• HalbwachsMecarelli L, Nusbaum P, Noel L H, Reumaux D, Erlinger S, Grunfeld J P, et al. Antineutrophil cytoplasmic antibodies (ANCA) directed against cathepsin G in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis. Clin. Exp. Immunol 1992; 90: 79–84
   PubMed Web of Science ®Google Scholar
• Uesugi H, Ozaki S, Sobajima J, Osakada F, Shirakawa H, Yoshida M, et al. Prevalence and characterization of novel pANCA, antibodies to the high mobility group non-histone chromosomal proteins HMG1 and HMG2, in systemic rheumatic diseases. J. Rheumatol 1998; 25: 703–9
   PubMed Web of Science ®Google Scholar
• Sobajima J, Ozaki S, Osakada F, Uesugi H, Shirakawa H, Yoshida M, et al. Novel autoantigens of perinuclear anti-neutrophil cytoplasmic antibodies (P-ANCA) in ulcerative colitis: non-histone chromosomal proteins, HMG1 and HMG2. Clin. Exp. Immunol 1997; 107: 135–40
   PubMed Web of Science ®Google Scholar
• Bustin M, Lehn D A, Landsman D. Structural features of the HMG chromosomal proteins and their genes. Biochim. Bio-phys. Acta 1990; 1049: 231–43
   PubMed Web of Science ®Google Scholar
• Sobajima J, Ozaki S, Uesugi H, Osakada F, Inoue M, Fukuda Y, et al. High mobility group (HMG) non-histone chromosomal proteins HMG1 and HMG2 are significant target antigens of perinuclear anti-neutrophil cytoplasmic antibodies in autoimmune hepatitis. Gut 1999; 44: 867–73
   PubMed Web of Science ®Google Scholar
• Sobajima J, Ozaki S, Uesugi H, Osakada F, Shirakawa H, Yoshida M, et al. Prevalence and characterization of perinuclear anti-neutrophil cytoplasmic antibodies (P-ANCA) directed against HMG1 and HMG2 in ulcerative colitis (UC). Clin. Exp. Immunol 1998; 111: 402–7
   PubMed Web of Science ®Google Scholar
• Hang L, Theofilopoulos A N, Dixon F J. A spontaneous rheumatoid arthritis-like disease in MRL/1 mice. J. Exp. Med. 1982; 155: 1690–701
   PubMed Web of Science ®Google Scholar
• Andrews B S, Eisenberg R A, Theofilopoulos A N, Izui S, Wilson C B, McConahey P J, et al. Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains. J. Exp. Med. 1978; 148: 1198–215
   PubMed Web of Science ®Google Scholar
• Theofilopoulos A N, Dixon F J. Autoimmune diseases: immu-nopathology and etiopathogenesis. Am. J. Pathol 1982; 108: 319–65
   PubMed Web of Science ®Google Scholar
• Hoffman R W, Alspaugh M A, Waggie K S, Durham J B, Walker S E. Sjögren's syndrome in MRL/1 and MRL/n mice. Arthritis Rheum 1984; 27: 157–65
   PubMed Web of Science ®Google Scholar
• Hoffman R W, Yang H K, Waggie K S, Durham J B, Burge J R, Walker S E. Band keratopathy in MRL/1 and MRL/n mice. Arthritis Rheum 1983; 26: 645–52
   PubMedGoogle Scholar
• Harper J M, Thiru S, Lockwood C M, Cooke A. Myeloperoxidase autoantibodies distinguish vasculitis mediated by anti-neutrophil cytoplasm antibodies from immune complex disease in MRL/Mp-lpr/lpr mice: a spontaneous model for human microscopic angiitis. Eur. J. Immunol 1998; 28: 2217–26
   PubMed Web of Science ®Google Scholar
• Wiik A. Delineation of a standard procedure for indirect immunofluorescence detection of ANCA. APMIS. Suppl 1989; 6: 12–3
   PubMedGoogle Scholar
• Alexander E L, Moyer C, Travlos G S, Roths J B, Murphy E D. Two histopathologic types of inflammatory vascular disease in MRL/Mp autoimmune mice. Model for human vasculitis in connective tissue disease. Arthritis Rheum 1985; 28: 1146–55
   PubMed Web of Science ®Google Scholar
• Moyer C F, Strandberg J D, Reinisch C L. Systemic mononu-clear-cell vasculitis in MRL/Mp-lpr/lpr mice. A histologic and immunocytochemical analysis. Am. J. Pathol 1987; 127: 229–242
   PubMed Web of Science ®Google Scholar
• Wen L, Huang J K, Johnson B H, Reeck G R. A human placental cDNA clone that encodes nonhistone chromosomal protein HMG-l. Nucleic Acids Res 1989; 17: 1197–214
   PubMed Web of Science ®Google Scholar
• Majumdar A, Brown D, Kerby S, Rudzinski I, Polte T, Rand-Hawa Z. Sequence of human HMG2 cDNA. Nucleic Acids Res 1991; 19: 6643
   PubMed Web of Science ®Google Scholar
• Shirakawa H, Yoshida M. Structure of a gene coding for human HMG2 protein. J. Biol. Chem 1992; 267: 6641–5
   PubMed Web of Science ®Google Scholar
• Shirakawa H, Tsuda K, Yoshida M. Primary structure of nonhistone chromosomal protein HMG2 revealed by the nucleotide sequence. Biochemistry 1990; 29: 4419–23
   PubMed Web of Science ®Google Scholar
• Parkkinen J, Rauvala H. Interactions of plasminogen and tissue plasminogen activator (t-PA) with amphoterin. Enhancement of t-PA-catalyzed plasminogen activation by amphoterin. J. Biol. Chem 1991; 266: 16730–5
   PubMed Web of Science ®Google Scholar
• Parkkinen J, Raulo E, Merenmies J, Nolo R, Kajander E O, Baumann M, et al. Amphoterin, the 30-kDa protein in a family of HMGl-type polypeptides. Enhanced expression in transformed cells, leading edge localization, and interactions with plasminogen activation. J. Biol. Chem 1993; 268: 6–38, 1972
   Web of Science ®Google Scholar
• Wang H, Bloom O, Zhang M, Vishnubhakat J M, Ombrellino M, Che J, et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999; 285: 248–51
   PubMed Web of Science ®Google Scholar